sábado, 25 de abril de 2026

FDA to speed up review of three psychedelics as mental health treatments Compass, Usona, Transcend benefit from Trump’s embrace of psychedelics

https://www.statnews.com/2026/04/24/trump-psychedelic-drugs-fda-priority-review-mental-health-treatment/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-8ov9kmTDGchXVt9V_E5yJO9CNhFYzusw52-Xz67S7-b6sSQQfS7mFxX4Ivw_9ODsik9VyuhMIG8g_uE5dIjMJWgfqsBQ&_hsmi=415619628&utm_content=415619628&utm_source=hs_email By Elaine Chen, Damian Garde, and Daniel PayneApril 24, 2026

No hay comentarios: